Screener
Alamar Biosciences ALMR Product — Cost Of Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213424
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Service and other revenue | 4,694 | 3,922 |
| Total revenue | 26,035 | 13,091 |
| Cost of revenue: | ||
| Cost of product revenue | 9,810 | 5,371 |
| Cost of service and other revenue | 1,768 | 1,331 |
| Total cost of revenue | 11,578 | 6,702 |
| Gross profit | 14,457 | 6,389 |
| Operating expenses: |
Item 1. Financial Statements
FAQ
- What is Alamar Biosciences's product — cost of revenue?
- Alamar Biosciences (ALMR) reported product — cost of revenue of $9.81M in Q1 2026.
- What does product — cost of revenue mean?
- This metric captures the direct costs incurred to manufacture and deliver the company's proteomics products, including raw materials, labor, and overhead associated with production. It serves as a primary indicator of the company's manufacturing efficiency and the direct cost burden of supporting its installed base of instruments. Monitoring this helps assess the scalability of the production process as the company grows.
Ask your AI about Alamar Biosciences's product — cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude